Core Viewpoint - Tianjin Jianfa (02515) plans to issue up to 43.158 million placement shares at HKD 0.68 per share, representing a 15.0% discount to the last closing price of HKD 0.80 on the Hong Kong Stock Exchange [1] Group 1 - The company aims to raise approximately HKD 29.2 million from the placement [1] - The proceeds will be used to establish a new company for a machinery leasing platform, general working capital, and to seize future investment opportunities [1]

Core Viewpoint - Gilead Sciences-B (01672) shares rose nearly 9% in early trading, with a current price of HKD 16.45 and a trading volume of HKD 42.25 million, following a significant investment from the Government of Singapore Investment Corporation (GIC) [1][5]. Group 1 - GIC purchased approximately 64.12 million new shares of Gilead Sciences at an average price of HKD 12.18 per share, totaling around HKD 781 million, resulting in GIC holding a 6.42% stake in the company [1][5]. - The investment is part of Gilead Sciences' recent completion of a placement plan, where the company sold a total of 69.26 million shares, raising a net amount of approximately HKD 835 million [1][5]. - Gilead Sciences indicated that 90% of the funds raised will be allocated for the global Phase III clinical development of the oral small molecule GLP-1 receptor agonist ASC30, covering trial preparation, foundational work, and formal initiation; the remaining 10% will be used for operational funding [1][5].

Core Viewpoint - Yuegangwan Holdings (01396) has seen a significant stock increase of over 9%, attributed to its strategic financing and operational developments in AI cloud services [1] Group 1: Financial Performance - In the first half of 2025, Yuegangwan Holdings reported a net profit of 970 million HKD, a turnaround from a loss of 1.028 billion HKD in the same period of 2024 [1] - The company successfully completed a debt-to-equity conversion plan worth 440 million USD with a high approval rate of 98.33%, becoming the first domestic property stock to clear its offshore USD debt [1] Group 2: Strategic Developments - Yuegangwan Holdings announced a share placement financing of 108 million HKD, with approximately 70% allocated for the delivery of AI computing cloud services [1] - The company completed the acquisition of Tiandun Data for 977 million HKD in October last year, positioning itself as a leading player in intelligent computing operations with nearly 200 enterprise clients, including major cloud service providers and top AI companies [1] - Yuegangwan Holdings (Tiandun Data) has been designated as the official strategic partner for the AI Agent 2025 Global Intelligent Agent Ecosystem Summit [1]

Core Viewpoint - Yuegang Bay Holdings (01396) has seen a significant stock increase of over 9%, attributed to its strategic financing and operational developments in the AI sector [1] Group 1: Financial Performance - As of the latest report, Yuegang Bay Holdings' stock rose by 9.39%, reaching HKD 6.29, with a trading volume of HKD 19.07 million [1] - The company reported a turnaround in its financial performance, achieving a net profit of HKD 970 million in the first half of 2025, compared to a loss of HKD 1.028 billion in the same period of 2024 [1] Group 2: Strategic Initiatives - In December 2025, Yuegang Bay Holdings announced a placement financing of HKD 1.08 billion, with approximately 70% allocated for the delivery of AI computing cloud services [1] - The company completed the acquisition of Tiandun Data for HKD 977 million in October of the previous year, positioning itself as a leading operator in intelligent computing with nearly 200 enterprise clients, including major cloud service providers and top AI companies [1] - Yuegang Bay Holdings (Tiandun Data) has been designated as the official strategic partner for the AI Agent 2025 Global Intelligent Agent Ecosystem Summit [1] Group 3: Debt Management - On May 7, 2025, the company successfully passed a debt-to-equity conversion plan with a high approval rate of 98.33%, becoming the first domestic property company to nearly clear all of its offshore US dollar debt [1]

Group 1 - The company, Gao Shan Enterprises (00616), plans to place up to 115.88 million shares at a price of HKD 0.32 per share, which represents a premium of approximately 6.67% over the closing price of HKD 0.30 on the day of the announcement [1] - The maximum net proceeds from this placement are expected to be around HKD 36.71 million, which will be used to refinance existing bank loans by amending the terms of the loans [1]

Core Viewpoint - The company plans to issue up to 115.88 million placement shares at a price of HKD 0.32 per share, which is approximately 6.67% higher than the closing price of HKD 0.30 on the announcement date [1] Group 1 - The maximum net proceeds from the placement are expected to be approximately HKD 36.71 million [1] - The funds raised will be used to refinance existing bank loans by amending the terms of the loans [1]

Core Viewpoint - Ying Tai Medical (01501) announced a placement agreement to issue 35.2 million shares at a price of HKD 26 per share, representing a discount of approximately 16.13% from the closing price of HKD 31.00 on January 14, 2026 [1] Group 1 - The total net proceeds from the placement are expected to be approximately HKD 884 million [1] - 56.54% of the proceeds will be used for investments and potential acquisitions in the medical device industry to expand the company's product portfolio [1] - Approximately 23.75% of the proceeds will be allocated to repay existing interest-bearing bank loans [1] - About 19.71% of the proceeds will be utilized for general corporate purposes, including employee costs and daily operational expenses [1]

Core Viewpoint - Capital界金控 (00204.HK) plans to issue up to 41.5092 million new shares, representing approximately 16.67% of the enlarged issued share capital, at a price of HKD 0.183 per share, which is a discount of about 2.14% compared to the closing price of HKD 0.187 on December 24, 2025. The net proceeds from the placement are estimated to be approximately HKD 7.36 million, intended for future investment opportunities [1][1][1] Summary by Category Share Placement Details - The company intends to place a maximum of 41.5092 million new shares [1] - This represents about 16.67% of the enlarged issued share capital [1] - The placement price is set at HKD 0.183 per share, reflecting a discount of approximately 2.14% from the market closing price [1] Financial Implications - The estimated net proceeds from the share placement are around HKD 7.36 million, assuming full subscription and after deducting all related expenses [1] - The funds raised will be used to explore potential investment opportunities in the future [1]

Group 1 - The company, Sunshine Oil Sands (02012), plans to place up to approximately 114 million shares through Manhao Securities at a price of HKD 0.36 per share, representing a discount of about 10.00% compared to the closing price of HKD 0.40 on December 19, 2025 [1] - The maximum amount to be raised from this placement is approximately HKD 41.14 million, with a net amount of about HKD 40.31 million intended for general working capital [1]

Core Viewpoint - PACIFIC LEGEND (08547) experienced a significant decline of over 15%, trading at HKD 0.104, with a transaction volume of HKD 1.6391 million [1] Group 1: Stock Performance - As of the report, PACIFIC LEGEND's stock price dropped by 15.45% [1] - The stock was trading at HKD 0.104, down from a previous closing price of HKD 0.123 [1] Group 2: Fundraising Announcement - On December 10, PACIFIC LEGEND announced a placement of up to 98.5279 million shares, representing approximately 16.67% of the enlarged share capital [1] - The placement price is set at HKD 0.118 per share, reflecting a discount of about 4.07% compared to the closing price on December 10 [1] - The total amount raised from the placement is expected to be around HKD 11.6 million, with a net amount of approximately HKD 11.4 million intended for the group's working capital [1]